A case of acquired idiopathic generalized anhidrosis following severe acute respiratory syndrome coronavirus 2 vaccination

The Journal of DermatologyEarly View LETTER TO THE EDITOR Author reply to “Response to ‘A case of acquired idiopathic generalized anhidrosis following severe acute respiratory syndrome coronavirus 2 vaccination’” Reiko Kageyama, Reiko Kageyama Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, JapanSearch for more papers by this authorAtsuyoshi Ginoza, Atsuyoshi Ginoza orcid.org/0000-0002-3201-1041 Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, JapanSearch for more papers by this authorTetsuya Honda, Corresponding Author Tetsuya Honda [email protected] Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan Correspondence Tetsuya Honda, Department of Dermatology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan. Email: [email protected]Search for more papers by this author Reiko Kageyama, Reiko Kageyama Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, JapanSearch for more papers by this authorAtsuyoshi Ginoza, Atsuyoshi Ginoza orcid.org/0000-0002-3201-1041 Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, JapanSearch for more papers by this authorTetsuya Honda, Corresponding Author Tetsuya Honda [email protected] Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan Correspondence Tetsuya Honda, Department of Dermatology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan. Email: [email protected]Search for more papers by this author First published: 07 September 2023 https://doi.org/10.1111/1346-8138.16946Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Hsieh CY, Tsai TF. Acquired idiopathic generalized anhidrosis diagnosed following mRNA COVID-19 vaccination—a case series. Australas J Dermatol. 2023; 64: e76–e79. 2Ginoza A, Kageyama R, Suzuki N, Shimauchi T, Fujiyama T, Ito T, et al. A case of acquired idiopathic generalized anhidrosis following severe acute respiratory syndrome coronavirus 2 vaccination. J Dermatol. 2023; 50: e249–e250. 3Sano K, Asahina M, Araki N, Uehara T, Iwaya M, Okuyama R. Type 1 interferon signature and cytotoxic T lymphocyte activation targeted against sweat ducts in inflammatory acquired idiopathic generalized anhidrosis. J Eur Acad Dermatol Venereol. 2023. https://doi.org/10.1111/jdv.19284 4Yamaguchi Y, Kato Y, Edahiro R, Søndergaard JN, Murakami T, Amiya S, et al. Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells. JCI Insight. 2022; 7:e163347. 5Arunachalam PS, Scott MKD, Hagan T, Li C, Feng Y, Wimmers F, et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021; 596: 410–416. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation